Prognostic implication of cardiovascular comorbidities in the evolution of patients with COPD exacerbation, admitted to ICU
Section: Artículos Científicos
Authors
Verónica Sierra Soto1, David Esteve Casanovas1, Carmen Rodríguez Triviño2, Yolanda Torralba García3, Xavier Alsina-Restoy3
Position
1 MSc. Enfermera/o asistencial. Unidad de Vigilancia Intensiva Respiratoria del Hospital Clínic de Barcelona. 2 MSc. Enfermera asistencial. Servicio Oftalmología del Parc Taulí Hospital Universitari. 3 MSc. Enfermera/o asistencial Servicio Neumología del Hospital Clínic de Barcelona.
Contact address
Verónica Sierra Soto. Unidad de Vigilancia Intensiva Respiratoria. Hospital Clínic de Barcelona. C/ Villaroel, 170. 08036 Barcelona
Contact email: vsierra@clinic.cat
Abstract
Introduction and objectives. Cardiovascular disease is highly prevalent in patients with chronic obstructive pulmonary disease. The objective of the study was to assess whether the presence of cardiac disease effected the evolution of the patient admitted for exacerbation of COPD in an intensive care unit.
Material and methods. An observational, retrospective, case-control study was carried out. The two study groups, both with a previous diagnosis of chronic obstructive pulmonary disease and admitted for exacerbation, were grouped according to the presence or absence of known associated heart disease. The same demographic variables, presence of cardiovascular risk factors, degree of severity of the disease, need for vasopressors, mechanical ventilation, length of stay, readmissions and mortality were evaluated in both groups.
Results and conclusions. 73 patients were included, 38 (52%) with known associated cardiovascular disease. A high prevalence of cardiovascular risk factors was observed. A correlation was observed between sex, age and the presence of cardiovascular disease. The group without heart disease had more active smokers (p <0.05). A significant relationship was observed between the group with cardiovascular disease and dyslipidemia (p <0.05). There were no differences in readmissions or mortality at 6-months. The presence of structural heart disease did not effect the evolution of the patient with chronic obstructive pulmonary disease, although an incomplete diagnosis of cardiac disease, or early stage disease, could have led to some asymptomatic patients with cardiovascular risk factors having some type of silent heart disease.
Keywords:
pulmonary disease; chronic obstructive; Intensive Care Units; Cardiovascular diseases; comorbidity; echocardiography Doppler; ventricular dysfunction; heart failure
Versión en Español
Título:
Artículo completo no disponible en este idioma / Full article is not available in this language
Bibliography
1. Caram L, Ferrari R, Naves C, Tanni S, Coelho L, Zanati S, et al. Association between left ventricular diastolic dysfunction and severity of chronic obstructive pulmonary disease. Clinics [Internet]. 2013 Jun 7 [cited 2017 Nov 11];68(6):772–6.
2. Akkutuk E, Karakurt Z, Salturk C, Burunsuzoglu B, Kargin F, Horzum G, et al. How do COPD comorbidities affect ICU outcomes? Int J Chron Obstruct Pulmon Dis [Internet]. 2014 Oct [cited 2017 Nov 20];9:1187.
3. Müllerova H, Maselli DJ, Locantore N, Vestbo J, Hurst JR, Wedzicha JA, et al. Hospitalized Exacerbations of COPD. Chest [Internet]. 2015 Apr [cited 2017 Nov 20];147(4):999–1007.
4. Vogelmeier CF, Criner GJ, Martinez FJ, Anzueto A, Barnes PJ, Bourbeau J, et al. Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease 2017 Report. GOLD Executive Summary. Am J Respir Crit Care Med [Internet]. 2017 Mar 1 [cited 2017 Nov 20];195(5):557–82.
5. Dixit D, Bridgeman MB, Andrews LB, Narayanan N, Radbel J, Parikh A, et al. Acute exacerbations of chronic obstructive pulmonary disease: diagnosis, management, and prevention in critically ill patients. Pharmacotherapy [Internet]. 2015 Jun [cited 2017 Nov 20];35(6):631–48.
6. Díez-Manglano J, Recio Iglesias J, Varela Aguilar JM, Almagro Mena P, Zubillaga Garmendia G, los investigadores del estudio COREPOC en nombre del grupo de E de la SE de MI. Effectiveness of a simple intervention on management of acute exacerbations of chronic obstructive pulmonary disease and its cardiovascular comorbidities: COREPOC study. Med Clin (Barc) [Internet]. 2017 Sep 20 [cited 2017 Nov 12];149(6):240–7.
7. Figueira Gonçalves JM, Dorta Sánchez R, Rodri Guez Pérez MDC, Viña Manrique P, Díaz Pérez D, Guzmán Saenz C, et al. Cardiovascular comorbidity in patients with chronic obstructive pulmonary disease in the Canary Islands (CCECAN study). Clin Investig Arterioscler [Internet]. 2017 Jul [cited 2017 Nov 12];29(4):149–56.
8. Stankovic I, Marcun R, Janicijevic A, Farkas J, Kadivec S, Ilic I, et al. Echocardiographic predictors of outcome in patients with chronic obstructive pulmonary disease. J Clin Ultrasound [Internet]. 2017 May [cited 2017 Nov 11];45(4):211–21.
9. Müllerova H, Agusti A, Erqou S, Mapel DW. Cardiovascular Comorbidity in COPD. Chest [Internet]. 2013 Oct [cited 2017 Nov 15];144(4):1163–78.
10. Corlateanu A, Covantev S, Mathioudakis AG, Botnaru V, Siafakas N. Prevalence and burden of comorbidities in Chronic Obstructive Pulmonary Disease. Respir Investig [Internet]. 2016 Nov [cited 2017 Nov 12];54(6):387–96.
11. Freixa X, Portillo K, Paré C, Garcia-Aymerich J, Gomez FP, Benet M, et al. Echocardiographic abnormalities in patients with COPD at their first hospital admission. Eur Respir J [Internet]. 2013 Apr [cited 2017 Nov 11];41(4):784–91.
12. Cazzola M, Calzetta L, Rinaldi B, Page C, Rosano G, Rogliani P, et al. Management of Chronic Obstructive Pulmonary Disease in Patients with Cardiovascular Diseases. Drugs [Internet]. 2017 May 28 [cited 2017 Nov 12];77(7):721–32.
13. Matamis D, Tsagourias M, Papathanasiou A, Sineffaki H, Lepida D, Galiatsou E, et al. Targeting occult heart failure in intensive care unit patients with acute chronic obstructive pulmonary disease exacerbation: effect on outcome and quality of life. J Crit Care [Internet]. 2014 Apr [cited 2017 Nov 20];29(2):315.e7-14.
14. Papaioannou AI, Bartziokas K, Loukides S, Tsikrika S, Karakontaki F, Haniotou A, et al. Cardiovascular comorbidities in hospitalised COPD patients: a determinant of future risk? Eur Respir J [Internet]. 2015 Sep [cited 2018 Jun 13];46(3):846–9.
15. Roversi S, Fabbri LM, Sin DD, Hawkins NM, Agustí A. Chronic Obstructive Pulmonary Disease and Cardiac Diseases. An Urgent Need for Integrated Care. Am J Respir Crit Care Med [Internet]. 2016 Dec 1 [cited 2018 Jun 4];194(11):1319–36.
16. Jones PW, Mullerova H, Agusti A, Decramer M, Adamek L, Raillard A, et al. Cardiovascular disease does not predict exacerbation rate or mortality in COPD. AJRCCM Artic Press [Internet]. [cited 2017 Nov 10];201706–1066.
17. Yoshihisa A, Takiguchi M, Shimizu T, Nakamura Y, Yamauchi H, Iwaya S, et al. Cardiovascular function and prognosis of patients with heart failure coexistent with chronic obstructive pulmonary disease. J Cardiol [Internet]. 2014 Oct [cited 2018 Jun 4];64(4):256–64.
18. de Miguel Díez J, García TG, Maestu LP. Comorbilidades de la EPOC. Arch Bronconeumol [Internet]. 2010 Jan [cited 2017 Dec 13];46:20–5.
19. Galaznik A, Chapnick J, Vietri J, Tripathi S, Zou KH, Makinson G. Burden of smoking on quality of life in patients with chronic obstructive pulmonary disease. Expert Rev Pharmacoecon Outcomes Res [Internet]. 2013 Dec 9 [cited 2018 Jun 17];13(6):853–60.
20. Hvidtfeldt UA, Rasmussen S, Grønbaek M, Becker U, Tolstrup JS. Influence of smoking and alcohol consumption on admissions and duration of hospitalization. Eur J Public Health [Internet]. 2010 Aug 1 [cited 2018 Jun 13];20(4):376–82.